Congressmen Mike Michaud (R-ME), Dan Burton (R-IN) and TimRyan (D-OH) wrote House Energy and Commerce calling for a hearing to examinealleged conflicts of interest involving FDA’s decision not to approve Provenge.They said “there is reason to believe that serious ethics rules were violatedby two FDA advisory panel members.”